Evidence map›Paper›PMID 31707971›Full record

ArticleTechnology in cancer research & treatment

The Risk of Radiogenic Second Cancer Based on Differential DVH: Central Nervous System Malignant Tumor in Children.

Zheng Tang, Xue Zou, Qian Luo, Ying Wang, Fu Jin

Open access · goldAbstract read
In one paragraph

Article in Technology in cancer research & treatment. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Tomotherapy for cranio-spinal irradiation.Clinical and translational radiation oncology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Zheng TangChongqing University Cancer Hospital, Chongqing, China.
Xue ZouChongqing University Cancer Hospital, Chongqing, China.ORCID 0000-0002-7905-2158
Qian LuoChongqing University Cancer Hospital, Chongqing, China.
Ying WangChongqing University Cancer Hospital, Chongqing, China.
Fu JinChongqing University Cancer Hospital, Chongqing, China.
Chongqing University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo quantify the risk of radiogenic second cancer in pediatric patients receiving hippocampal-sparing craniospinal irradiation either with intensity-modulated radiation therapy or tomotherapy due to the development of a solid second cancer after radiotherapy using the concept of excess absolute risk.

methodsComputed tomography images of 15 pediatric patients who received craniospinal irradiation treatment were selected for this study. For each case, intensity-modulated radiation therapy and tomotherapy plans were computed. Then, the dosimetry parameters were analyzed. Differential dose-volume histograms were generated, and the excess absolute risks were calculated for each plan of each patient.

resultsThe tomotherapy group was superior to the intensity-modulated radiation therapy group in target area homogeneity index (

conclusionsThe tomotherapy plan has obvious advantages in the protection of the hippocampus for children undergoing craniospinal irradiation treatment. Tomotherapy increased the risk of radiogenic second cancer in organ at risk, and therefore, it is imperative to take the risk factor into consideration in the formulation of treatment protocols.

Indexed as

AdolescentAge FactorsAlgorithmsCentral Nervous System NeoplasmsChildChild, PreschoolCraniospinal IrradiationFemaleHippocampusHumansMaleModels, TheoreticalNeoplasms, Second PrimaryOrgans at RiskRadiotherapyRadiotherapy Dosagecraniospinal irradiationintensity-modulated radiotherapyrisk of radiogenic second cancertomotherapy

Identifiers

PMID31707971
PMCPMC6843732
OpenAlexW2983239380

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.